Comprehensive Care for Joint Replacement

By Brian Dolan July 7, 2016
New York City-based Force Therapeutics raised $2.6 million, according to an SEC filing. This brings the company's total funding to date to about $4.8 million. The company's original investors include former OpenTable CEO Thomas Layton; former CEO of Revolution Health and TicketMaster, John Pleasants; and FiveW Capital Managing Member Randall Winn. Force Therapeutics has developed a mobile and web...